To the best of our knowledge, this study reveals for the first time that estrogen promotes BRCA1-deficient tumor initiation and progression by stimulation of cell proliferation and activation of EMT, which are dependent on AKT activation and independent of ER. This evidence concerns the gene AKT1 and neoplasm.